Past-President of the European Cancer Organisation Prof Niall O’Higginshighlights the important topic of cancer survivors, which he argues deserves the full attention of Irish legislators and should be supported by the medical profession The EU Beating Cancer Plan, setting out the European Union’s strategy for cancer care, will be launched this month. It will be given …

By 2022, projections estimate that 18 million people will be cancer survivors and by 2023, 2.3 million people will be newly diagnosed with cancer.[1] But significant challenges remain when it comes to ensuring high-quality, patient-centered, and proactive care for this growing population. Most oncologists agree that social determinants of health (SDOH) – such as financial, housing, and …

Deposing the ‘Emperor of All Maladies’ will take a diverse toolkit, not a single moonshot. On the campaign trail, President-elect Joe Biden repeatedly promised that as president he’d lead America to a massive healthcare victory — not over COVID, but over cancer. “I promise you if I’m elected president, you’re going to see the single most …

Oncology professionals mostly agreed that telehealth promotes access to care, but they had differing opinions on cost and clinical effectiveness. Medical oncology professionals had differing opinions on the clinical effectiveness, financial impact, and patient experience of virtual care, while most agreed that telehealth provided patients with better access to care, according to a new study published in JAMA …

During the pandemic, people have been getting less medical treatment. That saves money, but it could harm their health, an economist says. Cutting waste while preserving critically important treatment is the holy grail of health care policy. The coronavirus pandemic has shown why that goal has been so stubbornly difficult to achieve. One of the pandemic’s startling effects is …

Mothers and fathers of children diagnosed with cancer are affected financially in different ways. While mothers’ incomes fall in the short term and then rise, the adverse financial repercussions on fathers occur later. Researchers at Uppsala University have investigated the socioeconomic impact on parents of having a child diagnosed with cancer. The study is published …

With multi-center clinical trials in Israel, US and UK, Israeli startup OncoHost hopes to launch life-saving test kit in 2021 Immunotherapy, one of the most promising treatments for cancer, can cost up to $100,000 per patient – and choosing the wrong course of treatment can actually expand, rather than shrink, a tumor. OncoHost, an Israeli startup, …

The toll from COVID is immense, with more than 90 million people affected and nearly 2 million dead across the world. Yet these numbers don’t tell the full story. The pandemic’s collateral damage in other diseases, like cancer, is rising and will only make itself fully felt in the next few years.  According to recent data from …

Birthing a drug isn’t easy. It’s an intensive, unpredictable, and enormously stressful endeavor which can dash the hopes of the world’s greatest scientific minds and the patients they seek to serve. Initial clinical trial victories can quickly swerve into cataclysmic failures.  But that reality, and the unique nature of the pharmaceutical industry’s life-changing mission, gets messy when it …

A study of simulated patients with primary epithelial ovarian cancer found that none of the maintenance therapy regimens evaluated were cost-effective when compared with observation following frontline response. Results from a study published in JAMA Network Open suggested that the current cost of maintenance therapy for primary ovarian cancer is not cost-effective, regardless of molecular signature. “Maintenance …